Position in IMRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,281
+$19,441 QoQ
Shares Held
4,866
+190.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 111 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $62,741,652 across 267 Biotechnology names. IMRX ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,422 | $6,170,379 | |
| 2 | EXEL |
Exelixis, Inc.
|
75,969 | $4,133,473 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
40,729 | $3,187,858 | |
| 4 | CYTK |
Cytokinetics Inc
|
36,992 | $3,151,348 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,939,634 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,593 | $2,863,919 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,547 | $2,782,480 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
25,923 | $2,112,983 |
All Filings in IMRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,281 | 4,866 | Shares | Other | 2026-08-13 | |
| 2024-03-31 | $4,840 | 1,675 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $12,311 | 1,675 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $12,864 | 1,675 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $16,984 | 1,675 | Shares | Other | 2023-08-11 | |
| 2022-03-31 | $4,101 | 634 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $10,251 | 634 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $16,832 | 634 | Shares | Other | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||